Inhibition of the MET oncogene kinase domain or ligand binding site abrogates an invasive phenotype in human colorectal cancer

被引：0
|
作者：
Francone, T. D.
Chen, T. C.
Sun, M.
Zeng, Z.
Nakamura, T.
Matsumoto, K.
Paty, P. B.
Weiser, M. R.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Osaka Univ, Grad Sch Med, Osaka, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2007年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [21] Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells
    Chen, Hui-Jye
    Jiang, Yi-Lin
    Lin, Chung-Ming
    Tsai, Shih-Chang
    Peng, Shu-Fen
    Fushiya, Shinji
    Hour, Mann-Jen
    Yang, Jai-Sing
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (01) : 141 - 150
  • [22] THE LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR-GAMMA IS PREDOMINANTLY ALPHA-HELICAL WITH A TRP RESIDUE IN THE LIGAND-BINDING SITE
    LUPISELLA, JA
    DRISCOLL, JE
    METZLER, WJ
    RECZEK, PR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) : 24884 - 24890
  • [23] Analysis of the ligand-binding domain of human retinoic acid receptor alpha by site-directed mutagenesis
    Lamour, FPY
    Lardelli, P
    Apfel, CM
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (10) : 5386 - 5392
  • [24] c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells
    Lin, Yueh-Ming
    Lu, Chien-Chang
    Hsiang, Yi-Ping
    Pi, Shu-Chuan
    Chen, Chih-I
    Cheng, Kung-Chuan
    Pan, Hsiao-Lin
    Chien, Pei-Hsuan
    Chen, Yun-Ju
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 10336 - 10344
  • [25] The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells
    Wei, Ning
    Chu, Edward
    Wu, Shao-yu
    Wipf, Peter
    Schmitz, John C.
    ONCOTARGET, 2015, 6 (07) : 4745 - 4756
  • [26] Structural and Genetic Analyses of the Mycobacterium tuberculosis Protein Kinase B Sensor Domain Identify a Potential Ligand-binding Site
    Prigozhin, Daniil M.
    Papavinasasundaram, Kadamba G.
    Baer, Christina E.
    Murphy, Kenan C.
    Moskaleva, Alisa
    Chen, Tony Y.
    Alber, Tom
    Sassetti, Christopher M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (44) : 22961 - 22969
  • [27] INHIBITION OF PROTEIN-KINASE-C BY MELITTIN - ANTAGONISM OF BINDING INTERACTIONS BETWEEN MELITTIN AND THE CATALYTIC DOMAIN BY ACTIVE-SITE BINDING OF MGATP
    GRAVITT, KR
    WARD, NE
    OBRIAN, CA
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) : 425 - 427
  • [28] Chemical Inhibition of Human Thymidylate Kinase and Structural Insights into the Phosphate Binding Loop and Ligand-Induced Degradation
    Chen, Yi-Hsuan
    Hsu, Hua-Yi
    Yeh, Ming-Tyng
    Chen, Chen-Cheng
    Huang, Chang-Yu
    Chung, Ying-Hsuan
    Chang, Zee-Fen
    Kuo, Wei-Chen
    Chan, Nei-Li
    Weng, Jui-Hsia
    Chung, Bon-chu
    Chen, Yu-Ju
    Jian, Cheng-Bang
    Shen, Ching-Chieh
    Tai, Hwan-Ching
    Sheu, Sheh-Yi
    Fang, Jim-Min
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (21) : 9906 - 9918
  • [29] Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-alpha or the erbB2 proto-oncogene
    Connolly, JM
    Rose, DP
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (01) : 71 - 76
  • [30] ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non-Small Cell Lung Cancer
    Kabbout, Mohamed
    Garcia, Melinda M.
    Fujimoto, Junya
    Liu, Diane D.
    Woods, Denise
    Chow, Chi-Wan
    Mendoza, Gabriela
    Momin, Amin A.
    James, Brian P.
    Solis, Luisa
    Behrens, Carmen
    Lee, J. Jack
    Wistuba, Ignacio I.
    Kadara, Humam
    CLINICAL CANCER RESEARCH, 2013, 19 (13) : 3383 - 3395
12345